However, Mi-2β silencing combined with anti-PD-1 treatment conferred a substantial inhibition of tumor growth in B16F10 melanoma cells (Fig. 1a, b), and subsequently extended the survival of the treated mice (Fig. 1c). This evidence concerns the gene CHD4 and melanoma.